Literature DB >> 3455620

Effect of age on circulating immunoreactive and bioactive parathyroid hormone levels in women.

M S Forero1, R F Klein, R A Nissenson, K Nelson, H Heath, C D Arnaud, B L Riggs.   

Abstract

Although levels of serum immunoreactive parathyroid hormone (iPTH) increase with age in women, this could be caused by retention of non-biologically active PTH fragments by the aging kidney. In 102 normal women, aged 30 to 89 yr, serum iPTH increased with age by 58% (r = 0.33, p less than 0.001) with antiserum GP-1M (which has midmolecule specificity) and 43% (r = 0.32, p less than 0.001) with antiserum CH-12M (which may have whole molecule specificity); urinary cAMP/GFR excretion increased by 29% (r = 0.22, p less than 0.05). The results of these assays were validated by comparison with serum levels of biologically active PTH (BioPTH) in immunoextracts of serum followed by renal adenylate cyclase assay in a selected subgroup of 25 of the women. Serum BioPTH correlated with serum iPTH assessed by antiserum GP-1M (r = 0.48, p less than 0.05) and antiserum CH-12M (r = 0.48, p less than 0.05) but not with urinary cAMP. The data are consistent with an increase of parathyroid function with aging: clearly, we do not find decreased parathyroid function as would be expected if age-related bone loss was not mediated, in part, by PTH.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3455620     DOI: 10.1002/jbmr.5650020502

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  10 in total

Review 1.  Prevention of secondary hyperparathyroidism and hip fracture in elderly women with calcium and vitamin D3 supplements.

Authors:  M C Chapuy; P J Meunier
Journal:  Osteoporos Int       Date:  1996       Impact factor: 4.507

Review 2.  Use of calciferol and its metabolites and analogues in osteoporosis. Current status.

Authors:  A M Parfitt
Journal:  Drugs       Date:  1988-11       Impact factor: 9.546

Review 3.  Overview of osteoporosis.

Authors:  B L Riggs
Journal:  West J Med       Date:  1991-01

4.  Vitamin D status as the major factor determining the circulating levels of parathyroid hormone: a study in normal subjects.

Authors:  Jessica Pepe; Elisabetta Romagnoli; Italo Nofroni; Maria Teresa Pacitti; Simona De Geronimo; Claudio Letizia; Gianfranco Tonnarini; Addolorata Scarpiello; Emilio D'Erasmo; Salvatore Minisola
Journal:  Osteoporos Int       Date:  2004-11-16       Impact factor: 4.507

Review 5.  Can we stop bone loss and prevent hip fractures in the elderly?

Authors:  P J Meunier; M C Chapuy; M E Arlot; P D Delmas; F Duboeuf
Journal:  Osteoporos Int       Date:  1994       Impact factor: 4.507

6.  Disturbed calcium metabolism in subjects with elevated diastolic blood pressure.

Authors:  H Reichel; R Liebethal; H W Hense; H Schmidt-Gayk; E Ritz
Journal:  Clin Investig       Date:  1992-09

7.  Desensitization to parathyroid hormone in renal cells from aged rats is associated with alterations in G-protein activity.

Authors:  H Hanai; C T Liang; L Cheng; B Sacktor
Journal:  J Clin Invest       Date:  1989-01       Impact factor: 14.808

8.  Effects of estrogen on circulating "free" and total 1,25-dihydroxyvitamin D and on the parathyroid-vitamin D axis in postmenopausal women.

Authors:  C Cheema; B F Grant; R Marcus
Journal:  J Clin Invest       Date:  1989-02       Impact factor: 14.808

Review 9.  Calcium metabolism and vitamin D in the extreme longevity.

Authors:  Giovanni Passeri; Rosanna Vescovini; Paolo Sansoni; Carlo Galli; Claudio Franceschi; Mario Passeri
Journal:  Exp Gerontol       Date:  2007-07-04       Impact factor: 4.032

10.  Primary hyperparathyroidism in older people: surgical treatment with minimally invasive approaches and outcome.

Authors:  Chiara Dobrinja; Marta Silvestri; Nicolò de Manzini
Journal:  Int J Endocrinol       Date:  2012-06-12       Impact factor: 3.257

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.